Adenocarcinoma is a type of cancer that starts in the cells that line glands. Glands are small organs that make and release substances like mucus, oil, or hormones. Cancers starting in glands are called adenocarcinomas.
Every report comes from a Lived member, sent anonymously.
Have you had Chemotherapy infusion for Adenocarcinoma?
Adenocarcinoma is cancer that begins in glandular cells, the cells lining many organs that make mucus, digestive juices or other fluids. When these cells start to grow out of control, they can form a tumor that invades nearby tissue and may spread elsewhere in the body. The word describes the type of cell a cancer comes from, not a single disease. Most cancers of the breast, colon and rectum, and prostate are adenocarcinomas, as are the most common forms of lung, pancreatic and stomach cancer, and of esophageal cancer in the US. Because of this, an adenocarcinoma of the lung and one of the prostate behave very differently and are treated differently. What matters most for any one person is where the cancer started, how far it has spread and how the cells look under a microscope. When adenocarcinoma spreads, it keeps the name of its starting point. Breast adenocarcinoma that reaches the lung is still breast cancer, and it is usually treated as breast cancer.
Adenocarcinoma develops when changes build up in the DNA (the genetic instructions inside each cell) of glandular cells, letting them divide without the usual controls. Some of these changes come from exposures such as tobacco smoke, some are inherited and many accumulate with age, which is one reason cancer becomes more common later in life. The specific risk factors depend on the organ. Smoking raises the risk of several types, including lung adenocarcinoma. Long-term acid reflux that causes Barrett's esophagus (a change in the lining of the lower esophagus) is linked to esophageal adenocarcinoma. Excess body weight, heavy alcohol use, previous radiation therapy and a family history of cancer can also raise risk for certain types. A risk factor makes cancer more likely but does not mean a person will develop it, and many people with adenocarcinoma have no clear risk factor at all.
Diagnosis usually starts with symptoms, a screening test or an unexpected finding on a scan. Symptoms depend on the organ involved: a lasting cough or coughing up blood for the lung, blood in the stool or a change in bowel habits for the colon, trouble swallowing for the esophagus. Some types, including many pancreatic and prostate adenocarcinomas, cause few symptoms until they are advanced, and some breast and colorectal adenocarcinomas are found through routine screening before any symptoms appear. Imaging such as a CT (computed tomography) scan, which combines many X-rays into detailed images, or MRI (magnetic resonance imaging, which uses magnets and radio waves) shows where an abnormal area is and whether it may have spread. Only a biopsy confirms the diagnosis: a small piece of tissue is removed and examined by a pathologist, a doctor who diagnoses disease from cells and tissue. The pathology report gives the grade, which describes how abnormal the cells look. Well-differentiated (low-grade) cells resemble normal tissue and tend to grow more slowly; poorly differentiated (high-grade) cells look more abnormal and tend to grow and spread faster. Doctors then assign a stage, which is different from grade: it describes the size of the tumor and how far it has spread, from stage 0 (confined to where it began) to stage IV (spread to distant parts of the body). The tumor may also be tested for biomarkers, genes or proteins that can guide treatment choices. Occasionally adenocarcinoma is found where it has spread, but its starting point cannot be identified. This is called cancer of unknown primary, and treatment is planned from the information that is available.
Treatment depends on where the cancer started, its stage and grade, its biomarkers and the person's overall health and preferences. Most people are cared for by a team that may include a surgeon, a medical oncologist and a radiation oncologist. Surgery to remove the tumor and some surrounding tissue is usually the first treatment when the cancer has not spread widely. Radiation therapy uses high-energy beams to kill cancer cells in a targeted area, and is often combined with surgery or chemotherapy. Chemotherapy uses drugs that travel through the body to kill fast-growing cells; it may be given before surgery to shrink a tumor, after surgery to lower the chance of return, or as the main treatment when the cancer has spread. Biomarker results increasingly shape treatment. Targeted therapies act on specific genetic changes in the cancer and help only when that change is present, so testing comes first. Immunotherapy helps the immune system recognize and attack cancer, and certain test results, such as the level of PD-L1 (a protein that can help cancer cells hide from the immune system) on the tumor cells, suggest who is more likely to benefit. Hormone therapy is used for adenocarcinomas that depend on hormones to grow, such as some breast and prostate cancers. When adenocarcinoma has spread to distant organs, treatment often aims to control the cancer, extend life and relieve symptoms rather than to cure it, although this differs by type. Clinical trials, including some that enroll people by their tumor's biomarkers rather than its organ, are an option worth asking about at any stage. Side effects vary with each treatment; tiredness, nausea, appetite loss and pain are common after surgery and during chemotherapy, and the care team can help manage them.
The outlook ranges widely. Some adenocarcinomas, such as many found early in the breast, colon or prostate, are highly treatable, while others, such as most pancreatic adenocarcinomas, are often found late and are harder to treat. The organ, the stage at diagnosis and the response to treatment matter far more than the cell type alone. Survival statistics describe large groups of people diagnosed in the past and cannot predict any one person's course. Treatment often lasts weeks to months and can affect work, energy, eating and family routines. Many people combine treatments, one after another, and recovery from each step takes time. Support with nutrition, pain, emotional health and practical matters such as finances is a normal part of cancer care, not an extra. After treatment ends, follow-up visits, scans and blood tests check for any return of the cancer and for late effects of treatment. How often these happen depends on the type and stage, and usually becomes less frequent over time.
Make an appointment if a cough, trouble swallowing, ongoing abdominal or pelvic pain or unexplained weight loss lasts longer than two weeks without explanation, or sooner if symptoms are interfering with daily life. Get checked promptly, without waiting to see whether it persists, if you notice blood in your urine or stool, cough up blood or find a new breast lump. Keep up with recommended cancer screening, since several adenocarcinomas can be found before symptoms appear. Coughing up more than a small streak of blood, or coughing up blood along with trouble breathing or chest pain, is an emergency: call 911 or go to the nearest emergency department. During treatment, contact your care team promptly about new or worsening symptoms or side effects; they can tell you which problems need same-day care for your specific treatment. A fever of 100.4 F (38 C) or higher during chemotherapy needs a call to the care team right away, even at night or on a weekend, because it can be a sign of a serious infection when white blood cell counts are low. Follow the team's after-hours instructions.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Adenocarcinoma is like, what's helped you, or ask the community a question.